91st General Assembly · Funnel one-pager · Monday, November 9, 2026
HF 590: Relating to manufacturers and distributors of 340B drugs
Died when the session ended · The General Assembly adjourned on October 2, 2026. Bills that didn’t pass both chambers died.
What it does
This bill relates to manufacturers and distributors of 340B drugs. “340B drug”, “manufacturer”, and “distributor” are defined in the bill. The bill prohibits a manufacturer or distributor from, directly or indirectly, denying, restricting, or interfering with the acquisition of a 340B drug by a covered entity, or the delivery of a 340B drug to a contract pharmacy, unless otherwise prohibited by the United States department of health and human services.
Sponsors
Rep. Brett Barker (R)
Cost
No fiscal note
Lobbying · 3 for, 6 against
For: Iowa Association of Rural Health Clinics; Iowa Pharmacy Association; Iowa Primary Care Association
Against: Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb Co.; GSK; Healthcare Distribution Alliance c/o MultiState Associates LLC; Iowa Biotechnology Association; Pharmaceutical Research and Manufacturers of America (PhRMA)
In plain words
- February 25, 2025Filed in the House and sent to the Health and Human Services committee
From public records at legis.iowa.gov, compiled by Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Monday, November 9, 2026. https://iowafunnel.com/bills/91/HF590